PLACE OF LOW-MOLECULAR-WEIGHT HEPARINS IN INTENSIVE THERAPY OF HEPATIC INSUFFICIENCY
https://doi.org/10.15372/SSMJ20200115
Abstract
The practical significance of heparin low-molecular fractions as inhibitors of inflammation and antithrombin III consumption reduction were studied. That is most critical in acute hepatic failure. The study was performed using the low-molecular-weight heparin (Nadroparin calcium) in low (prophylactic) doses of 2000 anti-factor Xa units daily per 1 meter squared in the form of continuous intravenous infusion. The cohort study proved the nadroparin positive effect on carbohydrate and protein metabolism in children with acute poisoning by hepatotoxic poisons, The significant decrease in the quantitative assessment of disseminated intravascular coagulation relative to the comparison group has been revealed, and the decrease in 28-day mortality from 42 to 13 % has been found in children receiving nadroparin. Conclusions are drawn on the feasibility of introducing low molecular weight heparins into the intensive care regimen of liver failure.
About the Authors
A. N. Shmakov
Novosibirsk State Regional Clinical Hospital,
Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
Russian Federation
doctor of medical sciences, professor,
http://orcid.org/0000-0002 -6214-3897
630087, Novosibirsk, Nemirovich-Danchenko str., 130
630091, Novosibirsk, Krasny av., 52
K. V. Budarova
Novosibirsk State Regional Clinical Hospital,
Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
candidate of medical sciences
Russian Federation
candidate of medical sciences
630087, Novosibirsk, Nemirovich-Danchenko str., 130
630091, Novosibirsk, Krasny av., 52
N. L. Elizareva
Novosibirsk State Regional Clinical Hospital,
Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
doctor of medical sciences, assistant professor
Russian Federation
doctor of medical sciences, assistant professor
630087, Novosibirsk, Nemirovich-Danchenko str., 130
630091, Novosibirsk, Krasny av., 52
V. N. Kohno
Novosibirsk State Regional Clinical Hospital
Russian Federation
doctor of medical sciences, professor
Russian Federation
doctor of medical sciences, professor
630087, Novosibirsk, Nemirovich-Danchenko str., 130
References
1. Weltishchev Yu.E. Water-salt exchange of children. Moscow: Meditsina, 1967. 325 p. [In Russian].
2. Kuznik B.I., Sturov V.G., Maksimova O.G. Hemorrhagic and thrombotic diseases and syndromes in children. Novosibirsk: Nauka, 2012. 456 p. [In Russian].
3. Loskutova S.A. The rationale for anticoagulant therapy in children with glomerulonephritis. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2008; (7): 66–71. [In Russian].
4. Chuprova A.V., Shmakov A.N., Solov’ev O.N. Intensification of therapy of DIC in children based on the use of low molecular weight heparins. Anesteziologiya i reanimatologiya = Russian Journal of Anaesthesiology and Reanimatology. 2002; 1: 29–31. [In Russian].
5. Chuprova A.V., Loskutova S.A., Shmakov A.N. Controlled anticoagulant therapy in pediatrics. Pediatriya = Pediatrics. 2004; (2): 52–57. [In Russian].
6. Chalmers E., Ganesen V., Liesner R., Maroo S., Nokes T., Saunders D., Williams M. Guideline on the investigation, management and prevention of venous thrombosis in children. Br. J. Haematol. 2011; 154 (2): 196–207. doi: 10.1111/j.1365-2141.2010.08543.x
7. Dabbous M.K., Sakr F.R., Malaeb D.N. Anticoagulant therapy in pediatrics. J. Basic Clin. Pharm. 2014; 5 (2): 27–33. doi: 10.4103/0976-0105.134947
8. Hofmann S., Knoefler R., Lorenz N., Siegert G., Wendisch J., Mueller D., Taut-Sack H., Dinger J., Kabus M. Clinical experiences with low-molecular weight heparins in pediatric patients. Thromb. Res. 2001; 103 (5): 345–353. doi: 10.1016/S0049-3848(01)00335-8
9. Law C., Raffini L. A guide to the use of anticoagulant drugs in children. Paediatr. Drugs. 2015; 17 (2): 105–114. doi: 10.1007/s40272-015-0120-x
10. Monagle P., Chan A.K., Goldenberg N.A., Ichord R.N., Journeycake J.M., Nowak-Gottl U., Vesely S.K. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2, Suppl): 737S–801S. doi: 10.1378/chest.11-2308
11. Raffini L., Huang Y.S., Witmer C., Feudtner C. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics. 2009; 124 (4): 1001–1008. doi: 10.1542/peds.2009-0768
Review
For citations:
Shmakov A.N., Budarova K.V., Elizareva N.L., Kohno V.N. PLACE OF LOW-MOLECULAR-WEIGHT HEPARINS IN INTENSIVE THERAPY OF HEPATIC INSUFFICIENCY. Сибирский научный медицинский журнал. 2020;40(1):110-114. (In Russ.) https://doi.org/10.15372/SSMJ20200115
Views:
202
Email this article 